Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA approves new drug-eluting balloon | AI's role in EP | Screening for valve dysfunction after TAVR | AHA to honor surgeon
Tuesday, September 22, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.

READ MORE >
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.
READ MORE >

AI gaining ground in electrophysiology, but clinicians still run the show

Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care. 

READ MORE >
Sanjiv Narayan, MBChB, MD, MSc, FRCP, an American Heart Association volunteer, Director of the Electrophysiology Research and Atrial Fibrillation Program, and Co-Founder of the Stanford Arrhythmia Center, at Stanford Medicine, spoke in sessions at the European Society of Cardiology (ESC) 2026 Congress about the use of artificial intelligence in AFib care, using smarter detection to enable better outcomes.
Share on Twitter Share on Facebook Share on Linkedin

AI gaining ground in electrophysiology, but clinicians still run the show

Share on Twitter Share on Facebook Share on Linkedin
Sanjiv Narayan, MBChB, MD, MSc, FRCP, an American Heart Association volunteer, Director of the Electrophysiology Research and Atrial Fibrillation Program, and Co-Founder of the Stanford Arrhythmia Center, at Stanford Medicine, spoke in sessions at the European Society of Cardiology (ESC) 2026 Congress about the use of artificial intelligence in AFib care, using smarter detection to enable better outcomes.
Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care. 
READ MORE >

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 
READ MORE >

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 

READ MORE >
Jennifer S. Lawton, MD
Share on Twitter Share on Facebook Share on Linkedin

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Share on Twitter Share on Facebook Share on Linkedin
Jennifer S. Lawton, MD
Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 
READ MORE >

Featured Articles

Chronic stress linked to heart damage, other risks in new imaging study

Researchers tracked data from more than 480,000 U.K. Biobank participants, using cardiac MRI scans to identify signs of inflammation. 

READ MORE >
suicide prevention depression
Share on Twitter Share on Facebook Share on Linkedin

Chronic stress linked to heart damage, other risks in new imaging study

Share on Twitter Share on Facebook Share on Linkedin
suicide prevention depression
Researchers tracked data from more than 480,000 U.K. Biobank participants, using cardiac MRI scans to identify signs of inflammation. 
READ MORE >

3D printing, VR playing a major role in congenital heart imaging

3D models can improve the visualization of challenging cardiac anatomy in addition to supporting clinical decision-making, education and procedural planning.

READ MORE >
Kanwal Farooqi, MD, pediatric cardiology imaging specialist, and associate professor of pediatrics at Columbia University Irving Medical Center, innovations for clinical 3D printing and virtual reality in cardiac CT imaging aimed at structural and congenital heart patients.
Share on Twitter Share on Facebook Share on Linkedin

3D printing, VR playing a major role in congenital heart imaging

Share on Twitter Share on Facebook Share on Linkedin
Kanwal Farooqi, MD, pediatric cardiology imaging specialist, and associate professor of pediatrics at Columbia University Irving Medical Center, innovations for clinical 3D printing and virtual reality in cardiac CT imaging aimed at structural and congenital heart patients.
3D models can improve the visualization of challenging cardiac anatomy in addition to supporting clinical decision-making, education and procedural planning.
READ MORE >

American Heart Association works to improve care for women with chronic kidney disease

Women with CKD often receive a delayed diagnosis and are less likely to receive a kidney transplant. These trends mean, among other things, those women face an increased risk of developing heart disease.

READ MORE >
acute kidney injury after TAVR
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association works to improve care for women with chronic kidney disease

Share on Twitter Share on Facebook Share on Linkedin
acute kidney injury after TAVR
Women with CKD often receive a delayed diagnosis and are less likely to receive a kidney transplant. These trends mean, among other things, those women face an increased risk of developing heart disease.
READ MORE >

European Society of Cardiology joins effort to improve access to heart data

Accessing cardiology data for research or population health initiatives is still quite difficult in Europe. Could this new project help reverse that trend? 

READ MORE >
Example of a cardiology image report with graphical display of the coronaries for notation in the Fujifilm Synapse 7X CVIS system. #ACC23 #ACC
Share on Twitter Share on Facebook Share on Linkedin

European Society of Cardiology joins effort to improve access to heart data

Share on Twitter Share on Facebook Share on Linkedin
Example of a cardiology image report with graphical display of the coronaries for notation in the Fujifilm Synapse 7X CVIS system. #ACC23 #ACC
Accessing cardiology data for research or population health initiatives is still quite difficult in Europe. Could this new project help reverse that trend? 
READ MORE >

In Case You Missed It

Cath lab procedure kits recalled due to ongoing safety concern

The manifolds inside these kits have been linked to a significant risk of contamination.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Cath lab procedure kits recalled due to ongoing safety concern

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The manifolds inside these kits have been linked to a significant risk of contamination.
READ MORE >

FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes

The popular diabetes drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.

READ MORE >
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
The popular diabetes drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.
READ MORE >

No significant sex-based differences in timing of care for M-TEER patients

Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

No significant sex-based differences in timing of care for M-TEER patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.
READ MORE >

In Other News

HHS-OIG audit finds that major Medicare Advantage insurers engaged in $180M of alleged upcoding

The payers in question, Humana and UnitedHealthcare, deny any wrongdoing and are not obligated to pay back any money. 

READ MORE >
Humana
Share on Twitter Share on Facebook Share on Linkedin

HHS-OIG audit finds that major Medicare Advantage insurers engaged in $180M of alleged upcoding

Share on Twitter Share on Facebook Share on Linkedin
Humana
The payers in question, Humana and UnitedHealthcare, deny any wrongdoing and are not obligated to pay back any money. 
READ MORE >

More radiologists now devoting their practices to interventional radiology, Medicare analysis shows

A new analysis examines trends in the concentration of interventional radiology work among radiologists from 2008 through 2023.

READ MORE >
Interventional radiologist radiology IR genicular artery embolization surgery. Images courtesy of the University of Chicago Medicine
Share on Twitter Share on Facebook Share on Linkedin

More radiologists now devoting their practices to interventional radiology, Medicare analysis shows

Share on Twitter Share on Facebook Share on Linkedin
Interventional radiologist radiology IR genicular artery embolization surgery. Images courtesy of the University of Chicago Medicine
A new analysis examines trends in the concentration of interventional radiology work among radiologists from 2008 through 2023.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiologists named to USPSTF | The top children’s heart hospitals | A decade of success | Record-breaking attendance
FDA approves new drug-eluting balloon | AI's role in EP | Screening for valve dysfunction after TAVR | AHA to honor surgeon
AEDs recalled | Soccer player sues her cardiologist | FDA approves small leadless pacemaker | J&J sells heart tech to startup
Scientific statement takes on CKD in women | The growing roles of 3D printing & VR | Chronic stress & the heart | Unlocking data
BP drug recalled | FDA approves new leadless pacemaker | Early reactions to TAVR changes | Cardiologists accused of fraud
New data on BP changes in women | Intravascular imaging & PCI | Catheters linked to injury risk | Stroke rehab recommendations
Practice-changing research | Cardiologists named to USPSTF | Soccer player sues her cardiologist | Biotech company secures grant
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup